Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

OBJECTIVES: We evaluated the prognostic impact of a novel C-reactive protein (CRP) cut-off value (0.6 mg/dl) and carcinoembryonic antigen (CEA)/carbohydrate antigen 19-9 (CA19-9) in stage II/III colorectal cancer. METHODS: Four hundred ninety-eight patients with stage II (n = 275) or stage III (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Ushigome, Mitsunori, Shimada, Hideaki, Kaneko, Tomoaki, Miura, Yasuyuki, Nagashima, Yasuo, Suzuki, Takayuki, Kagami, Satoru, Kurihara, Akiharu, Funahashi, Kimihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Society of Coloproctology 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613415/
https://www.ncbi.nlm.nih.gov/pubmed/36348944
http://dx.doi.org/10.23922/jarc.2022-010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613415/
https://www.ncbi.nlm.nih.gov/pubmed/36348944
http://dx.doi.org/10.23922/jarc.2022-010

Ejemplares similares